Know Cancer

or
forgot password
  • cancer clinical trials in cincinnati, OH

  • Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Oncology & Hematology Care
    Cincinnati, Ohio 45236
    Multiple Myeloma
    Phase II Study in Patients With Operable Breast Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Breast Cancer
    Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Gestational Trophoblastic Tumor
    Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Prostate Cancer
    Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Lung Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Brain and Central Nervous System Tumors
    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Extraocular Retinoblastoma
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Leukemia
    Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
    UIMA, Inc / University of Cincinnati-Barrett Cancer Center
    Cincinnati, Ohio 45267
    NSCLC
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
    Cincinnati Children's
    Cincinnati, Ohio 45229
    Tuberous Sclerosis Complex
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Colorectal Cancer
    Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
    University of Cincinnati

    Trial Locations
    University of Cincinnati
    Veterans Administration Medical Center - Cincinnati
    Stage IV Pancreatic Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    North Treatment Center - Blue Ash Medical Center

    Trial Locations
    North Treatment Center - Blue Ash Medical Center
    Oncology/Hematology Care Clinical Trials LLC, Cincinnati, OH Blue Ash Med. Cntr. (Administrative Only)
    Oncology/Hematology Care Clinical Trials LLC
    Breast Cancer
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    The Jewish Hospital
    Cincinnati, Ohio 45236
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neurofibromatosis Type 1
    N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Leukemia
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Non Small Cell Lung Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    University of Cincinnati / Barrett Cancer Center Dept.of Internal Med.
    Cincinnati, Ohio 45219
    Myelogenous Leukemia, Chronic
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Good Samaritan Hospital Cancer Treatment Center
    Cincinnati, Ohio 45220
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
    Bethesda North Hospital
    Cincinnati, Ohio 45242
    Breast Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Multiple Ascending Dose (MDX1105-01)
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Cancer, Multiple Indications
    A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
    Christ Hospital
    Cincinnati, Ohio 45219
    Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Renal Cell Carcinoma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Carcinoma
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Lung Cancer
    A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Osteosarcoma
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Non-small Cell Lung Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Barrett Cancer Center
    Cincinnati, Ohio 45267-0502
    Melanoma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    A Multicenter Clinical Study of the Sonablate®500 for the Treatment of Locally Recurrent Prostate Cancer With HIFU
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Recurrent Prostate Cancer
    A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
    Oncology Hematology Care

    Trial Locations
    Oncology Hematology Care
    The Christ Hospital
    B-cell Chronic Lymphocytic Leukemia
    Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
    Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
    Cincinnati, Ohio 45229-3039
    Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
    Cincinnati Children's Hospital and Medical Center
    Cincinnati, Ohio 45229
    Juvenile Idiopathic Arthritis
    Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Tuberous Sclerosis, Angiolipoma
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    The Jewish Hospital
    Cincinnati, Ohio 45236
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Good Samaritan Hospital - Cincinnati

    Trial Locations
    Good Samaritan Hospital - Cincinnati
    University of Cincinnati
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Good Samaritan Hospital Cancer Treatment Center

    Trial Locations
    Good Samaritan Hospital Cancer Treatment Center
    Oncology Hematology Care, Incorporated - Blue Ash
    Endometrial Cancer, Fatigue, Neurotoxicity